Ignite Creation Date:
2025-12-24 @ 5:43 PM
Ignite Modification Date:
2025-12-25 @ 3:11 PM
Study NCT ID:
NCT06833268
Status:
COMPLETED
Last Update Posted:
2025-07-08
First Post:
2025-02-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Real-world Outcomes of Patients With HER2+ Metastatic Breast Cancer After Treatment With Trastuzumab Deruxtecan
Sponsor:
Daiichi Sankyo
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-01-20
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-06-16
Completion Date Type:
ACTUAL
First Submit Date:
2025-02-12
First Submit QC Date:
None
Study First Post Date:
2025-02-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-07
Last Update Post Date:
2025-07-08
Last Update Post Date Type:
ACTUAL